Poems syndrome with calciphylaxis: A case report

Acta Dermato-Venereologica

Volumn 91, Issue 1, 2011, Pages 96-97

  Lee, Fang Yu ^a   Chiu, Hsien Ching ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; ETOPOSIDE; MELPHALAN; PREDNISOLONE; PREDNISONE; THALIDOMIDE;

ADULT; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CELLULITIS; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DEBRIDEMENT; DISEASE ASSOCIATION; DYSPNEA; ERYTHEMA; GAIT DISORDER; GLOMERULOID HEMANGIOMA; HAND; HEMANGIOMA; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; HYPERTRICHOSIS; HYPERVOLEMIA; IMMUNOELECTROPHORESIS; IMPOTENCE; LABORATORY TEST; LEG; LEG EDEMA; LETTER; LIMB WEAKNESS; LIVER FUNCTION TEST; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; NERVE BIOPSY; NERVE CONDUCTION; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSCLEROSIS; PHYSICAL EXAMINATION; PLEURA EFFUSION; POEMS SYNDROME; PRIORITY JOURNAL; RISK FACTOR; SKIN BIOPSY; SKIN CALCIFICATION; SKIN DEFECT; SKIN NODULE; SYMPTOM; WEIGHT REDUCTION; WOUND HEALING;

CALCIPHYLAXIS; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PARANEOPLASTIC SYNDROMES; POEMS SYNDROME;

EID: 78751533661     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0969     Document Type: Letter

References (16)

1. Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Therneau TM, Larson DR, et al. POEMS syndrome: definitions and long-term outcome. Blood 2003; 101: 2496-2506.
2. De Roma I, Filotico R, Cea M, Procaccio P, Perosa F. Calciphylaxis in a patient with POEMS syndrome without renal failure and/or hyperparathyroidism. A case report. Ann Ital Med Int 2004; 19: 283-287.
3. Dispenzieri A. POEMS syndrome. Blood Rev 2007; 21: 285-299.
4. Gherardi RK, Belec L, Soubrier M, Malapert D, Zuber M, Viard JP, et al. Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome. Blood 1996; 87: 1458-1465.
5. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 1996; 347: 702.
6. Soubrier M, Dubost JJ, Serre AF, Ristori JM, Sauvezie B, Cathebras P, et al. Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor. Arthritis Rheum 1997; 40: 786-787.
7. Watanabe O, Maruyama I, Arimura K, Kitajima I, Arimura H, Hanatani M, et al. Overproduction of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve 1998; 21: 1390-1397.
8. Guldbakke KK, Khachemoune A. Calciphylaxis. Int J Dermatol 2007; 46: 231-238.
9. Weenig RH. Pathogenesis of calciphylaxis: Hans Selye to nuclear factor kappa-B. J Am Acad Dermatol 2008; 58: 458-471.
10. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 2000; 102: 2636-2642.
11. Mikhaylova L, Malmquist J, Nurminskaya M. Regulation of in vitro vascular calcification by BMP4, VEGF and Wnt3a. Calcif Tissue Int 2007; 81: 372-381.
12. Korkmaz C, Dundar E, Zubaroglu I. Calciphylaxis in a patient with rheumatoid arthritis without renal failure and hyperparathyroidism: the possible role of long-term steroid use and protein S deficiency. Clin Rheumatol 2002; 21: 66-69.
13. Zangari M, Esseltine D, Lee CK, Barlogie B, Elice F, Burns MJ, et al. Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma. Br J Haematol 2005; 131: 71-73.
14. Blade J, Cibeira MT, Rosinol L. Bortezomib: a valuable new antineoplastic strategy in multiple myeloma. Acta Oncol 2005; 44: 440-448.
15. Kaygusuz I, Tezcan H, Cetiner M, Kocakaya O, Uzay A, Bayik M. Bortezomib: a new therapeutic option for POEMS syndrome. Eur J Haematol 2009; 84: 175-177.
16. Tang X, Shi X, Sun A, Qiu H, Gu B, Zhou H, et al. Successful bortezomib-based treatment in POEMS syndrome. Eur J Haematol 2009; 83: 609-610.